Skip to content
DataLookout
Menu

MAGNET-VTNCT07896980

MRI-guided Ventricular Tachycardia Ablation in Patients With Structural Heart Disease

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Composite of ventricular tachycardia recurrence, cardiovascular hospitalization, or death
Timeframe: 12 months after the ablation procedure

Secondary (3)

Ventricular tachycardia recurrence rate at 6 months
Outcomes of the LGE-negative ablation registry cohort compared with the randomized patients
Incidence of ablation-related complications

Arms and interventions

LGE-MRI-integrated EAM-guided ablationExperimental

Patients undergo catheter ablation guided by integration of pre-procedural LGE-MRI scar imaging (ADAS-3D reconstruction) with electroanatomical mapping. In addition to conventional EAM-guided ablation, radiofrequency energy is delivered at the entrances of heterogeneous tissue channels identified on pixel signal intensity maps, regardless of local electrogram characteristics.

Conventional EAM-guided ablationActive comparator

Patients undergo catheter ablation guided by conventional three-dimensional electroanatomical mapping alone, without MRI image integration. Operators/mappers are blinded to the LGE-MRI findings.

Procedures: LGE-MRI-integrated EAM-guided catheter ablation, Conventional EAM-guided catheter ablation

Sites

1 site in 1 country

  • Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing, China